---
authors:
- Speer, Linda
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/39028792/
file_path: 2024/07/similar-rates-of-autism-with-lamotrigine-topiramate-and-no-t.md
issue: '1'
keywords:
- Humans
- Autistic Disorder
- Topiramate
- Fructose
- Lamotrigine
- Valproic Acid
- Anticonvulsants
- Female
- Male
- Child
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Lamotrigine
- Topiramate
- Valproic Acid
- Anticonvulsants
- Female
- Autistic Disorder
- Male
- Child
- Fructose
- Triazines
- Child, Preschool
original_format: PubMed
pages: 90-91
patient_population: Adults
peer_reviewed: true
pmid: '39028792'
processed_date: '2025-07-30'
publication_date: '2024-07-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Similar Rates of Autism With Lamotrigine, Topiramate, and No Treatment; Rate
  With Valproate Is Higher.
topics:
- Family Medicine
volume: '110'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '39028792'
  title: Similar Rates of Autism With Lamotrigine, Topiramate, and No Treatment; Rate
    With Valproate Is Higher.
  authors:
  - last_name: Speer
    fore_name: Linda
    initials: L
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '110'
    issue: '1'
  publication_info:
    year: '2024'
    month: '07'
    full_date: '2024-07-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Lamotrigine
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
    - qualifier: adverse effects
      major_topic: false
  - descriptor: Topiramate
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
    - qualifier: adverse effects
      major_topic: false
  - descriptor: Valproic Acid
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
    - qualifier: adverse effects
      major_topic: false
  - descriptor: Anticonvulsants
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
    - qualifier: adverse effects
      major_topic: false
  - descriptor: Female
    major_topic: false
  - descriptor: Autistic Disorder
    major_topic: false
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Male
    major_topic: false
  - descriptor: Child
    major_topic: false
  - descriptor: Fructose
    major_topic: false
    qualifiers:
    - qualifier: analogs & derivatives
      major_topic: false
    - qualifier: adverse effects
      major_topic: false
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Triazines
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
    - qualifier: adverse effects
      major_topic: false
  - descriptor: Child, Preschool
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '39028792'
  title: Similar Rates of Autism With Lamotrigine, Topiramate, and No Treatment; Rate
    With Valproate Is Higher.
  authors:
  - name: Speer L
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 Jul
- pmid: '17382828'
  title: 'The SANAD study of effectiveness of valproate, lamotrigine, or topiramate
    for generalised and unclassifiable epilepsy: an unblinded randomised controlled
    trial.'
  authors:
  - name: Marson AG
    authtype: Author
    clusterid: ''
  - name: Al-Kharusi AM
    authtype: Author
    clusterid: ''
  - name: Alwaidh M
    authtype: Author
    clusterid: ''
  - name: Appleton R
    authtype: Author
    clusterid: ''
  - name: Baker GA
    authtype: Author
    clusterid: ''
  - name: Chadwick DW
    authtype: Author
    clusterid: ''
  - name: Cramp C
    authtype: Author
    clusterid: ''
  - name: Cockerell OC
    authtype: Author
    clusterid: ''
  - name: Cooper PN
    authtype: Author
    clusterid: ''
  - name: Doughty J
    authtype: Author
    clusterid: ''
  - name: Eaton B
    authtype: Author
    clusterid: ''
  - name: Gamble C
    authtype: Author
    clusterid: ''
  - name: Goulding PJ
    authtype: Author
    clusterid: ''
  - name: Howell SJ
    authtype: Author
    clusterid: ''
  - name: Hughes A
    authtype: Author
    clusterid: ''
  - name: Jackson M
    authtype: Author
    clusterid: ''
  - name: Jacoby A
    authtype: Author
    clusterid: ''
  - name: Kellett M
    authtype: Author
    clusterid: ''
  - name: Lawson GR
    authtype: Author
    clusterid: ''
  - name: Leach JP
    authtype: Author
    clusterid: ''
  - name: Nicolaides P
    authtype: Author
    clusterid: ''
  - name: Roberts R
    authtype: Author
    clusterid: ''
  - name: Shackley P
    authtype: Author
    clusterid: ''
  - name: Shen J
    authtype: Author
    clusterid: ''
  - name: Smith DF
    authtype: Author
    clusterid: ''
  - name: Smith PE
    authtype: Author
    clusterid: ''
  - name: Smith CT
    authtype: Author
    clusterid: ''
  - name: Vanoli A
    authtype: Author
    clusterid: ''
  - name: Williamson PR
    authtype: Author
    clusterid: ''
  - name: SANAD Study group
    authtype: CollectiveName
    clusterid: ''
  source: Lancet
  pubdate: 2007 Mar 24
- pmid: '38507750'
  title: Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.
  authors:
  - name: Hernández-Díaz S
    authtype: Author
    clusterid: ''
  - name: Straub L
    authtype: Author
    clusterid: ''
  - name: Bateman BT
    authtype: Author
    clusterid: ''
  - name: Zhu Y
    authtype: Author
    clusterid: ''
  - name: Mogun H
    authtype: Author
    clusterid: ''
  - name: Wisner KL
    authtype: Author
    clusterid: ''
  - name: Gray KJ
    authtype: Author
    clusterid: ''
  - name: Lester B
    authtype: Author
    clusterid: ''
  - name: McDougle CJ
    authtype: Author
    clusterid: ''
  - name: DiCesare E
    authtype: Author
    clusterid: ''
  - name: Pennell PB
    authtype: Author
    clusterid: ''
  - name: Huybrechts KF
    authtype: Author
    clusterid: ''
  source: N Engl J Med
  pubdate: 2024 Mar 21
- pmid: '11206668'
  title: Evaluating the tolerability of the newer mood stabilizers.
  authors:
  - name: Alao AO
    authtype: Author
    clusterid: ''
  - name: Dewan MJ
    authtype: Author
    clusterid: ''
  source: J Nerv Ment Dis
  pubdate: 2001 Jan
- pmid: '20015083'
  title: Is anticonvulsant treatment of mania a class effect? Data from randomized
    clinical trials.
  authors:
  - name: Rosa AR
    authtype: Author
    clusterid: ''
  - name: Fountoulakis K
    authtype: Author
    clusterid: ''
  - name: Siamouli M
    authtype: Author
    clusterid: ''
  - name: Gonda X
    authtype: Author
    clusterid: ''
  - name: Vieta E
    authtype: Author
    clusterid: ''
  source: CNS Neurosci Ther
  pubdate: 2011 Jun
---

# Similar Rates of Autism With Lamotrigine, Topiramate, and No Treatment; Rate With Valproate Is Higher.

**Authors:** Speer, Linda

**Published in:** American family physician | Vol. 110, No. 1 | 2024-07-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/39028792/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Lamotrigine, Topiramate, Valproic Acid, Anticonvulsants, Female, Autistic Disorder, Male, Child, Fructose, Triazines, Child, Preschool

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/39028792/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
